Two main things are needed to break the bad guys. One is the new production facility and growing sales on the "big" market. The second is a shift at the point the expansion is generating significant sales revenues to a new investor/share trading pool made possible by being able to reach a much more wealthy set of people and institutions that do not buy penny stock for fiduciary and other reasons. This will require an exchange upgrade. A third very positive possibility is the almost certain approval and expansion of sales and/or marketing of the N-Assay technology to the huge medical supply company with which NanoLogix has been working. This is part of the first piece but there will be other customers for the N-Assay and the Flatpack system.